Bill Would Increase Funding for Pediatric Cancer Research in Iowa – YouTube
Pediatric cancer research funding is critical to advancing cannabis-based therapies for symptom management in young patients. This bill aims to increase support for such research in Iowa. Dedicated funding can help address unique pediatric considerations…
Cell Therapy Eases Parkinson’s Motor Symptoms in Early Trial
Cell therapy Parkinsons disease trials offer new hope for easing motor symptoms. Early-phase research suggests potential benefits in neurodegeneration treatment. Understanding these advances is crucial for clinicians and patients.
Governor Signs Bill to Launch Ibogaine Clinical Trials – Magnolia Tribune
Ibogaine clinical trials legislation marks a significant step in addiction treatment research. This bill enables formal studies to evaluate ibogaine's efficacy and safety. It opens regulatory pathways for controlled psychedelic clinical trials.
The First Randomized Trial Of Cannabis For Migraine Relief – And What It Found
This randomized controlled trial cannabis migraine study provides preliminary evidence on cannabis for migraine relief. It is the first controlled trial addressing this treatment area. Clinicians now have emerging data to guide migraine patient care.
Study Details | NCT07498023 | Effects of a Full Spectrum Cannabis Extract
This page covers the full spectrum cannabis extract clinical trial NCT07498023, highlighting its high clinical relevance. The study registration provides early insights into emerging cannabis research. Clinicians should evaluate the study design and…
Emerging Cannabis-Related Colorectal Cancer Treatment Research
Cannabis-related colorectal cancer treatment is currently being tested in clinical trials in West Michigan. This emerging research focuses on potential therapeutic effects and symptom management. Clinicians await peer-reviewed data to evaluate its…
New Funding to Support SER-252 Trial in Advanced Parkinson’s
The synthetic cannabinoid Parkinsons trial SER-252 targets levodopa-induced dyskinesia in advanced Parkinson's disease. This novel therapeutic approach could improve management of motor symptoms. Ongoing research aims to validate its clinical efficacy…
CBD Shows Promise But Lacks Broad Regulatory Approval: A Sobering Review of the Evidence
The CBD pharmacology regulatory context reveals a narrow evidence base supporting broad approval. Most CBD products lack pharmaceutical-grade quality and regulatory endorsement. This 2024 review highlights the need for rigorous clinical trials and…
Mapping the Clinical Trial Landscape for Cannabinoids in Neurology: A Registry-Based Systematic Review
This systematic review of cannabinoid clinical trials neurological disorders highlights research focused on Multiple Sclerosis, Fibromyalgia, and Parkinson's Disease. It reveals challenges due to inconsistent protocols and dosing across studies. The…
CBD and Anxiety: Promising Signal, Weak Evidence Base
The cbd anxiety clinical trials 2024 review reveals most studies are exploratory with varied designs and small samples. Evidence supporting CBD for anxiety disorders remains weak and inconclusive. This review highlights the urgent need for robust…